Iovance Biotherapeutics Inc header image

Iovance Biotherapeutics Inc

IOVA

Equity

ISIN US4622601007 / Valor 37313485

NASDAQ (2024-11-20)
USD 8.14-0.61%

Iovance Biotherapeutics Inc
UMushroom community rating:

star star star star star
5.00 2 votes No rating yet
NegativeNeutralPositive

About company

Iovance Biotherapeutics Inc is a company focused on innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapy for individuals with cancer. They are at the forefront of utilizing the human immune system to target and eliminate various cancer cells in each patient, with their TIL platform showing positive clinical results in various solid tumors. Additionally, the company is dedicated to advancing cell therapy through gene editing, offering potential new treatment options for cancer patients.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

48.3%1Y
-56.8%3Y
-64.6%5Y

Performance

89.7%1Y
91.7%3Y
86.9%5Y

Volatility

Market cap

2496 M

Market cap (USD)

Daily traded volume (Shares)

2,267,687

Daily traded volume (Shares)

1 day high/low

8.26 / 8.05

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

2 votes
Performance:
starstarstarstarstar
5.00
Innovation:
starstarstarstarstar
4.50
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
3.50
Alexander Priess
Switzerland, 28 Mar 2023
star star star star star
.
Luba Schoenig
Switzerland, 06 Dec 2022
star star star star star

EQUITIES OF THE SAME SECTOR

Moderna Inc
Moderna Inc Moderna Inc Valor: 44811242
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.94%USD 36.94
Ansys Inc
Ansys Inc Ansys Inc Valor: 492019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.80%USD 342.24
Concentrix Corporation
Concentrix Corporation Concentrix Corporation Valor: 58052752
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.71%USD 39.76
NAPCO Security Technologies Inc
NAPCO Security Technologies Inc NAPCO Security Technologies Inc Valor: 954486
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.04%USD 36.94
Soitec SA
Soitec SA Soitec SA Valor: 35180513
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.31%EUR 63.50
Instalco AB
Instalco AB Instalco AB Valor: 116212837
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.66%SEK 30.00
Stillfront Group AB
Stillfront Group AB Stillfront Group AB Valor: 59017394
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.83%SEK 6.60
BICO Group AB
BICO Group AB BICO Group AB Valor: 51871100
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%SEK 34.28
Carlo Gavazzi Holding AG
Carlo Gavazzi Holding AG Carlo Gavazzi Holding AG Valor: 127887756
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.51%CHF 198.00
RELIEF THERAPEUTICS Holding Ltd.
RELIEF THERAPEUTICS Holding Ltd. RELIEF THERAPEUTICS Holding Ltd. Valor: 125112599
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
15.58%CHF 5.34